|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2008-11-5
|
|
pubmed:abstractText |
Standard aspirin (acetylsalicylic acid [ASA])-dipyridamole therapy twice daily is associated with high rates of discontinuation in large part because of headache and gastrointestinal side effects. Attempts to address dipyridamole-induced headache through reduced dose initiation have produced variable results. Moreover, it has been suggested that migraineurs are more likely to have a dipyridamole-induced headache.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1532-8511
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
356-9
|
|
pubmed:meshHeading |
pubmed-meshheading:18984426-Adenosine,
pubmed-meshheading:18984426-Aged,
pubmed-meshheading:18984426-Aspirin,
pubmed-meshheading:18984426-Cerebral Arteries,
pubmed-meshheading:18984426-Cerebrovascular Circulation,
pubmed-meshheading:18984426-Dipyridamole,
pubmed-meshheading:18984426-Dose-Response Relationship, Drug,
pubmed-meshheading:18984426-Drug Administration Schedule,
pubmed-meshheading:18984426-Drug Synergism,
pubmed-meshheading:18984426-Drug Therapy, Combination,
pubmed-meshheading:18984426-Drug Tolerance,
pubmed-meshheading:18984426-Female,
pubmed-meshheading:18984426-Fibrinolytic Agents,
pubmed-meshheading:18984426-Headache,
pubmed-meshheading:18984426-Humans,
pubmed-meshheading:18984426-Male,
pubmed-meshheading:18984426-Migraine Disorders,
pubmed-meshheading:18984426-Phosphodiesterase Inhibitors,
pubmed-meshheading:18984426-Stroke,
pubmed-meshheading:18984426-Treatment Outcome,
pubmed-meshheading:18984426-Vasodilation
|
|
pubmed:articleTitle |
Titrated initiation of acetylsalicylic acid-dipyridamole therapy reduces adverse effects and improves tolerance in patients with stroke.
|
|
pubmed:affiliation |
Department of Neurology, Trillium Health Centre, Mississauga, Ontario, Canada. adouen@thc.on.ca
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
